scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | J Robinson Singleton | Q125193891 |
Eva Feldman | Q5415042 | ||
P2093 | author name string | James W Russell | |
A Gordon Smith | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microvessel | Q6840468 |
P1104 | number of pages | 7 | |
P304 | page(s) | 2867-2873 | |
P577 | publication date | 2003-12-01 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | Microvascular complications of impaired glucose tolerance | |
P478 | volume | 52 |
Q92967167 | 30-days effects of vildagliptin on vascular function, plasma viscosity, inflammation, oxidative stress, and intestinal peptides on drug-naïve women with diabetes and obesity: a randomized head-to-head metformin-controlled study |
Q37890777 | A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition |
Q35543708 | A novel animal model of impaired glucose tolerance induced by the interaction of vitamin E deficiency and (60)Co radiation. |
Q36424947 | A very low carbohydrate ketogenic diet prevents the progression of hepatic steatosis caused by hyperglycemia in a juvenile obese mouse model |
Q37385924 | A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project |
Q42073600 | Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo |
Q57246124 | Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes |
Q42918336 | American College Of Endocrinology Pre-Diabetes Consensus Conference: part one. |
Q35691890 | Anthrax lethal toxin suppresses high glucose induced VEGF over secretion through a post-translational mechanism |
Q39009713 | Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases. |
Q28390982 | Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells |
Q36727665 | Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy |
Q36593020 | Biomarkers of body iron stores and risk of developing type 2 diabetes |
Q38916549 | Biphasic effect of Solanum nigrum fruit aqueous extract on vascular mesenteric beds in non-diabetic and streptozotocin-induced diabetic rats. |
Q46891955 | Blood glucose and cerebrovascular disease in nondiabetic patients |
Q37379519 | Body mass index is associated with increased creatinine clearance by a mechanism independent of body fat distribution |
Q36939649 | Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis |
Q36152839 | Characterisation of morbidity in a UK, hospital based, obesity clinic. |
Q57922118 | Childhood Obesity and Insulin Resistance: How Should It Be Managed? |
Q58700390 | Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitus |
Q33610749 | Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy |
Q51297171 | Comparison of echocardiographic findings with laboratory parameters in obese children. |
Q40353553 | Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction |
Q35881459 | Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes |
Q50328302 | Cutaneous manifestations of diabetic peripheral neuropathy |
Q38360974 | Dapagliflozin: a new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes |
Q46011073 | Determination of nerve conduction abnormalities in patients with impaired glucose tolerance. |
Q85728487 | Diabetic neuropathies |
Q33554384 | Diabetic neuropathy: mechanisms to management |
Q37893102 | Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity |
Q46099822 | Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients |
Q39133016 | Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig. |
Q35761602 | Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes? |
Q47937998 | Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders |
Q27332290 | Early Cellular Changes in the Ascending Aorta and Myocardium in a Swine Model of Metabolic Syndrome |
Q34106165 | Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity |
Q87683460 | Elevated neurofilament light chain (NFL) mRNA levels in prediabetic peripheral neuropathy |
Q38712728 | Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes. |
Q89604879 | Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm |
Q46476732 | Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance |
Q34024860 | Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement |
Q38625575 | Exercise as Therapy for Diabetic and Prediabetic Neuropathy. |
Q39626888 | FOXO1 plays an essential role in apoptosis of retinal pericytes |
Q34580862 | Genome-wide association study of retinopathy in individuals without diabetes |
Q36232157 | Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study |
Q51391547 | HISS, not insulin, causes vasodilation in response to administered insulin |
Q55026843 | Hemorheologic Alterations in Patients with Type 2 Diabetes Mellitus Presented with an Acute Myocardial Infarction. |
Q33577717 | Hexosamine pathway but not interstitial changes mediates glucotoxicity in pancreatic β-cells as assessed by cytosolic Ca2+ response to glucose |
Q64121781 | High glucose level and angiotensin II type 1 receptor stimulation synergistically amplify oxidative stress in renal mesangial cells |
Q96304963 | Hyperinsulinemia contributes to impaired-glucose-tolerance-induced renal injury via mir-7977/SIRT3 signaling |
Q35691372 | IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis |
Q36957155 | Idiopathic neuropathy patients are at high risk for metabolic syndrome |
Q34238965 | Impact of diabetes and peripheral arterial occlusive disease on the functional microcirculation at the plantar foot |
Q43215429 | Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction |
Q38006758 | Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy |
Q101574248 | Incidence and risk factors of vascular complications in people with impaired fasting glucose: a national cohort study in Korea |
Q47436179 | Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy |
Q38338557 | Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90. |
Q51366750 | Insulin resistance increases risk of carpal tunnel syndrome: a case-control study. |
Q38488715 | Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients |
Q46581854 | Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. |
Q79308138 | Insulin-status-dependent modulation of FoF1-ATPase activity in rat liver mitochondria |
Q43044546 | Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species |
Q51368824 | Intramuscular injection of soluble receptor for advanced glycation endproducts expression vector prevents the development of streptozotocin-induced diabetes mellitus in rats on high fat diet. |
Q37967126 | Is there a divergence in time trends in the prevalence of impaired glucose tolerance and diabetes? A systematic review in South Asian populations. |
Q37125726 | Is vaspin related to cardio-metabolic status and autonomic function in early stages of glucose intolerance and in metabolic syndrome? |
Q38086281 | Lifestyle impact on meal-induced insulin sensitization in health and prediabetes: a focus on diet, antioxidants, and exercise interventions |
Q33729970 | Long-lasting effect of obesity on skeletal muscle transcriptome |
Q35584332 | Maternal salt and fat intake causes hypertension and sustained endothelial dysfunction in fetal, weanling and adult male resistance vessels. |
Q36012896 | Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes |
Q46801064 | Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats |
Q51310417 | Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study. |
Q36206352 | Microvascular Blood Flow Improvement in Hyperglycemic Obese Adult Patients by Hypocaloric Diet |
Q37579758 | Microvascular dysfunction in diabetic foot disease and ulceration. |
Q50459619 | Morphological restructuring of myocardium during the early phase of experimental diabetes mellitus |
Q35790594 | Myocardin-Related Transcription Factor A Epigenetically Regulates Renal Fibrosis in Diabetic Nephropathy |
Q37792183 | Neuropathy and impaired glucose tolerance: an updated review of the evidence |
Q37900473 | Neuropathy in prediabetes: does the clock start ticking early? |
Q35071239 | Neurovascular interaction and the pathophysiology of diabetic retinopathy |
Q33226200 | Non-invasive methods and stimuli for evaluating the skin's microcirculation. |
Q35225416 | One-hour postload plasma glucose levels and diastolic function in hypertensive patients |
Q35043292 | One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients |
Q43269412 | Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression. |
Q36755721 | Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. |
Q35060261 | Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004. |
Q37618185 | Physical therapy in the 21st century (Part I): toward practice informed by epidemiology and the crisis of lifestyle conditions |
Q34188567 | Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitus |
Q79999725 | Postprandial hyperglycemia alters inflammatory and hemostatic parameters |
Q45004937 | Potential antidiabetic effect of the Semecarpus anacardium in a type 2 diabetic rat model |
Q35390236 | Prediabetes as a Therapeutic Target |
Q46962040 | Predicting glucose intolerance with normal fasting plasma glucose by the components of the metabolic syndrome |
Q35975347 | Preoperative hyperglycemia and complication risk following neurosurgical intervention: A study of 918 consecutive cases |
Q36624270 | Prevalence of undiagnosed diabetes and pre-diabetes among hypertensive patients attending Kiambu district Hospital, Kenya: a cross-sectional study |
Q44091100 | Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge |
Q38442040 | Recent advances in glucose-lowering treatment to reduce diabetic kidney disease. |
Q35574984 | Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. |
Q48121111 | Retinal Photoreceptors and Microvascular Changes in Prediabetes Measured with Adaptive Optics (rtx1™): A Case-Control Study. |
Q37122850 | Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes |
Q92354662 | Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship |
Q37882225 | Screening for type 2 diabetes and dysglycemia |
Q36589206 | Serial anthropometry predicts peripheral nerve dysfunction in a community cohort |
Q44869345 | Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure. |
Q36366062 | Skin microvascular endothelial dysfunction is associated with type 2 diabetes independently of microalbuminuria and arterial stiffness. |
Q38086816 | Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus |
Q37587674 | Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus |
Q37249319 | Standing balance and trunk position sense in impaired glucose tolerance (IGT)-related peripheral neuropathy |
Q55669037 | Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol. |
Q34391710 | TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists |
Q35155923 | The "lipid accumulation product" is associated with 2-hour postload glucose outcomes in overweight/obese subjects with nondiabetic fasting glucose |
Q48053758 | The effect of high-dose vitamin D3 supplementation on bone mineral density in subjects with prediabetes |
Q36577293 | Therapy insight: neurological complications of prediabetes |
Q33393882 | Treatment of diabetic sensory polyneuropathy |
Q53173104 | Variables associated with corneal confocal microscopy parameters in healthy volunteers: implications for diabetic neuropathy screening. |
Q34965730 | Within-visit blood pressure variability is associated with prediabetes and diabetes |
Q51352541 | [Prediabetes: diagnosis, evaluation of chronic complications, and treatment]. |
Search more.